Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
Navigating Presbyopia Conversations with Patients in Practice
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Eyelid disease common among habitual scleral lens wearers, study finds
  • Contact Lenses

Eyelid disease common among habitual scleral lens wearers, study finds

Kelsey Moroz

Habitual scleral lens wear was associated with a high prevalence of eyelid disease in a recent study evaluating meibomian gland obstruction, meibum quality, and lid margin inflammation among regular wearers.

The study included 49 scleral lens wearers who had worn their current lenses for at least 6 months for a minimum of 5 hours per day, 6 days per week.

Upper lid wiper epitheliopathy was identified in 43% of eyes, while lower lid wiper epitheliopathy was present in 31% of eyes. In addition, 80% of eyes had expressible meibomian glands.

The researchers noted that eyes without expressible meibum were significantly more common in patients using scleral lenses for ocular surface disease compared with those wearing lenses for corneal irregularity (39% vs 11%; P = 0.03). Lid margin telangiectasia was also more prevalent in the ocular surface disease group than in the corneal irregularity group (61% vs 19%; P = 0.005).

Reference
Harthan JS, Nau A, Shorter E, et al. Presence of Eyelid Disease in Habitual Scleral Lens Wearers. J Clin Med. 2026;15(9):3181. doi: 10.3390/jcm15093181. PMID: 42122914; PMCID: PMC13164445.

Share

Related Content

  • Conference Roundup

Cash-pay dry eye marketing often outpaces available evidence

  • Conference Roundup

Affects dry eye can have on patients’ quality of life and more highlights from Academy 2026

  • Myopia

High-dose atropine plus dual-focus lenses show minimal myopia progression

  • Ocular Surface Disease

Apraclonidine 0.125% maintains ocular redness reduction over 8 weeks

  • Ocular Surface Disease

Greater screen use linked to dry eye symptoms in children

  • Ocular Surface Disease

Smartphone reminders improve short-term artificial tear adherence in dry eye disease

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon